Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss.
Permanent disability of patients suffering from central nervous system (CNS) inflammation such as multiple sclerosis, the most common chronic inflammatory disorder of the CNS, originates mainly from demyelination and axonal damage. Although many studies in the past focused on the role of CD4(+) T cells, several recent findings postulate the relevance of autoaggressive, cytotoxic CD8(+) T cells in the effector phase of multiple sclerosis. Yet, it remains unresolved whether axonal injury is the result of a CD8(+) T cell-targeted hit against the axon itself or the consequence of an attack against the myelin structure. To address this issue of CD8-mediated tissue damage in CNS inflammation, we performed continuous confocal imaging of autoaggressive, cytotoxic CD8(+) T cells in living organotypic cerebellar brain slices. We observed that loading brain slices with the cognate peptide antigen caused CD8-mediated damage of myelinated axons. To exclude the possibility that the cognate peptide loaded onto the brain slices was presented by axons directly, we restricted the cognate antigen expression exclusively to the cytosol of oligodendrocytes. Aside from vast myelin damage, extensive axonal bystander injury occurred. Using this model system of inflammatory CNS injury, we visualize that axonal loss can be the consequence from "collateral bystander damage" by autoaggressive, cytotoxic CD8(+) T cells, targeting their cognate antigen processed and presented by oligodendrocytes.
Sobottka
Bettina
B
Department of Neurology, Heinrich-Heine-University, Moorenstrasse 5, Duesseldorf, Germany.
Harrer
Melanie Denise
MD
Ziegler
Urs
U
Fischer
Katja
K
Wiendl
Heinz
H
Hünig
Thomas
T
Becher
Burkhard
B
Goebels
Norbert
N
D000818:Animals; D001324:Autoantigens / Q000276:immunology; D015551:Autoimmunity; D001369:Axons / Q000276:immunology / Q000473:pathology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002490:Central Nervous System / Q000276:immunology* / Q000473:pathology*; D003602:Cytotoxicity, Immunologic; D051379:Mice; D008822:Mice, Transgenic; D009103:Multiple Sclerosis / Q000209:etiology / Q000276:immunology* / Q000473:pathology; D009186:Myelin Sheath / Q000276:immunology* / Q000473:pathology*; D009836:Oligodendroglia / Q000276:immunology / Q000473:pathology / Q000648:ultrastructure; D009924:Organ Culture Techniques
D001324:Autoantigens
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2428-33
14983026
Nat Immunol. 2006 Sep;7(9):946-53
16906165
J Immunol. 2001 Jun 15;166(12):7579-87
11390514
Am J Pathol. 2001 Sep;159(3):809-15
11549572
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14145-50
14610278
J Mol Med (Berl). 2006 Jul;84(7):532-43
16773356
J Neurosci. 1998 Oct 15;18(20):8331-43
9763477
Blood. 2004 Jun 1;103(11):4222-31
14976054
J Immunol. 1996 Jul 15;157(2):679-88
8752917
J Immunol. 1998 Mar 15;160(6):3056-9
9510211
J Neurosci. 2007 Feb 21;27(8):2013-24
17314297
Annu Rev Immunol. 1999;17:369-97
10358763
J Immunol. 2008 Aug 1;181(3):1617-21
18641296
Mol Cell Neurosci. 1998 Dec;12(6):376-89
9888990
Brain. 2005 Aug;128(Pt 8):1747-63
15975943
J Exp Med. 2005 Jun 6;201(11):1805-14
15939794
J Exp Med. 2000 Aug 7;192(3):393-404
10934227
J Exp Med. 2001 Sep 3;194(5):669-76
11535634
J Neurosci. 2004 Mar 10;24(10):2458-64
15014121
N Engl J Med. 2006 Mar 2;354(9):942-55
16510748
Trends Neurosci. 2002 Jun;25(6):313-9
12086750
Eur J Immunol. 2006 Jan;36(1):207-15
16342234
J Neurosci Methods. 1991 Apr;37(2):173-82
1715499
Exp Neurol. 2009 Apr;216(2):431-8
19320002
J Exp Med. 1982 Jun 1;155(6):1823-41
6176669
Nat Immunol. 2001 Sep;2(9):762-4
11526378
Brain. 2008 Sep;131(Pt 9):2353-65
18669487
Trends Neurosci. 1997 Oct;20(10):471-7
9347615